← Open Payments lookup

ANGELA HAN: Open Payments

NPI 1629242839 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$360 in 14 payments from 8 companies in 2025. Trend: 2023 $411 · 2024 $449 · 2025 $360

Food & beverage: $360
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$134
Otsuka America Pharmaceutical, Inc.3$73
Teva Pharmaceuticals USA, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28
E.R. Squibb & Sons, L.L.C.1$26
Alkermes, Inc.1$20
Janssen Pharmaceuticals, Inc1$18
Lundbeck LLC1$17

Products named: INGREZZA, REXULTI, AUSTEDO XR, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, ARISTADA, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.